The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is set to undergo substantial growth between 2013 and 2023. The main drivers of growth will be the launch of monoclonal antibodies (mAbs) Empliciti and daratumumab, which will not only provide a new treatment option for MM patients, but will also lengthen the time between relapses, meaning that the duration of Revlimid and/or Velcade treatments will also be longer.
Label extensions of these mAbs, as well as of second-generation proteasome inhibitors ixazomib and Kyprolis, will further increase treatment options for these patients. The biggest constrainers of the Multiple Myeloma Market are the increasing cost-consciousness of healthcare providers, as the launch and subsequent label extensions of these pipeline agents will lead to a significant expense, which may impact uptake of these drugs.
Browse detailed TOC, Tables, figures, Charts and Companies mentioned in Multiple Myeloma – Global Drug Forecast and Market Analysis to 2023 Research Report at: http://www.marketreportsworld.com/pharmapoint-multiple-myeloma-global-drug-forecast-and-market-analysis-to-2023-10078301
– Overview of multiple myeloma, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
– Annualized multiple myeloma therapeutics market revenue, average cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
– Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the multiple myeloma therapeutics market.
– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
– Analysis of the current and future market competition in the global multiple myeloma therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Request Sample PDF of Multiple Myeloma Treatment Market Research Report at: http://www.marketreportsworld.com/enquiry/request-sample/10078301
The report will enable one to –
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
– Develop business strategies by understanding the trends shaping and driving the global multiple myeloma therapeutics market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global multiple myeloma therapeutics market in future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track drug sales in the global multiple myeloma therapeutics market from 2013-2023.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Purchase the Report at: http://www.marketreportsworld.com/purchase/10078301
Keyplayers Analyzed in PharmaPoint: Multiple Myeloma – Global Drug Forecast and Market Research Report are:
– Millennium Pharmaceuticals/Takeda
– Onyx Pharmaceuticals/Amgen
– Bristol-Myers Squibb
Ask for Discount on Multiple Myeloma Treatment Market at : http://www.marketreportsworld.com/enquiry/request-discount/10078301
No. of pages: 262
Single User Licence: $10995
Corporate User Licence: $32985
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Mr. Ameya Pingaley
Market Reports World
+1-408 520 9750
Email – email@example.com
For More Market Research News Related to Healthcare Industry Visit –